We are comparing a new treatment combining Amivantamab and chemotherapy to Cetuximab with chemotherapy for patients with certain types of colorectal cancer. This study aims to find out which option may help patients live longer without their cancer worsening.
Health conditions and diseases that the clinical trial is designed to study and treat.
Left-sided colorectal cancer is a type of cancer that occurs in the left side of the colon and may be unresectable or metastatic, meaning it cannot be surgically removed and has spread to other parts of the body. This subtype often has specific genetic markers, such as KRAS/NRAS and BRAF wild-type, which can influence treatment options.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
